Presentation TCT 2015 When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More Presenter: Robert A. Harrington October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 BRS Results to Date: Imaging, Randomized Trials, and Anticipation of ABSORB III Presenter: David G. Rizik October 11, 2015 More slides + Presentation TCT 2015 We Need More Data: STABLE and PREVENT Presenter: Seung-Jung Park October 11, 2015 Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Slow Down, Excess Bleeding, and No Mortality Benefit? Primum Non Nocere and Save Costs! Presenter: Tullio Palmerini October 11, 2015 We Recommend
Presentation TCT 2015 BRS Results to Date: Imaging, Randomized Trials, and Anticipation of ABSORB III Presenter: David G. Rizik October 11, 2015
Presentation TCT 2015 We Need More Data: STABLE and PREVENT Presenter: Seung-Jung Park October 11, 2015
Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Slow Down, Excess Bleeding, and No Mortality Benefit? Primum Non Nocere and Save Costs! Presenter: Tullio Palmerini October 11, 2015